Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

OX-219 shows promise in patients with opioid dependence

Sep. 22, 2011

Rare Disease Therapeutics selects distributor for Anascorp

Sep. 15, 2011

Pluristem's PLX cells show promise in preclinical studies

Sep. 9, 2011

BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone

Sep. 7, 2011

Duloxetine blocks psychostimulant effects

Sep. 5, 2011

Titan Pharmaceuticals schedules pre-NDA meeting for Probuphine

Sep. 1, 2011

ALL-00179 allows transdermal delivery of cannabidiol with microneedles

Aug. 22, 2011

PharmAthene receives Department of Defense contract for nerve agent medical countermeasure program

Aug. 17, 2011

First specific treatment for scorpion stings approved in U.S.

Aug. 5, 2011

Heroin-like immunoconjugate protects against addiction

Aug. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...